Which drugs does patent 8,466,175 protect, and when does it expire?
|Title:||Form of S-omeprazole|
|Abstract:||The present invention relates to a novel form of the (-)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-be- nzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.|
|Inventor(s):||Cotton; Hanna (Sodertalje, SE), Kronstrom; Anders (Sodertalje, SE), Mattson; Anders (Sodertalje, SE), Moller; Eva (Sodertalje, SE)|
|Assignee:||AstraZeneca AB (Sodertalje, SE)|
Patent Claim Types:|
see list of patent claims
|Use; Dosage form;|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|CAPSULE, DELAYED REL PELLETS;ORAL||021153-001||Feb 20, 2001||RX||Yes||No||8,466,175*PED||► Subscribe||Y|
|CAPSULE, DELAYED REL PELLETS;ORAL||021153-002||Feb 20, 2001||RX||Yes||Yes||8,466,175*PED||► Subscribe||Y|
|FOR SUSPENSION, DELAYED RELEASE;ORAL||021957-001||Oct 20, 2006||RX||Yes||No||8,466,175*PED||► Subscribe||Y|
|FOR SUSPENSION, DELAYED RELEASE;ORAL||021957-002||Oct 20, 2006||RX||Yes||Yes||8,466,175*PED||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Sweden||9702065||May 30, 1997|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.